메뉴 건너뛰기




Volumn 25, Issue 1, 2014, Pages

Emerging sequence type-269 serogroup B Neisseria meningitidis has the potential to cause outbreaks

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

EID: 84897397761     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2014/847192     Document Type: Letter
Times cited : (1)

References (17)
  • 1
    • 84866614844 scopus 로고    scopus 로고
    • Serogroup A meningococcal conjugate-vaccination in Burkina Faso: Analysis of national surveillance data
    • Novak RT, Kambou JL, Diomandé FVK, et al. Serogroup A meningococcal conjugate-vaccination in Burkina Faso: Analysis of national surveillance data. Lancet Infect Dis 2012;12:757-64.
    • (2012) Lancet Infect Dis , vol.12 , pp. 757-764
    • Novak, R.T.1    Kambou, J.L.2    Diomandé, F.V.K.3
  • 2
    • 3242768475 scopus 로고    scopus 로고
    • Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
    • DOI 10.1016/S0140-6736(04)16725-1, PII S0140673604167251
    • Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004;364:365-7. (Pubitemid 38970013)
    • (2004) Lancet , vol.364 , Issue.9431 , pp. 365-367
    • Trotter, C.L.1    Andrews, N.J.2    Kaczmarski, E.B.3    Miller, E.4    Ramsay, M.E.5
  • 3
    • 34250801673 scopus 로고    scopus 로고
    • An advisory committee statement (ACS) on conjugate meningococcal vaccine for serogroups A, C, Y and W135
    • National Advistory Committee on Immunization (NACI)
    • National Advistory Committee on Immunization (NACI). An advisory committee statement (ACS) on conjugate meningococcal vaccine for serogroups A, C, Y and W135. Canada Communicable Disease Report 2007;33(ACS3):1-24.
    • (2007) Canada Communicable Disease Report , vol.33 , Issue.ACS3 , pp. 1-24
  • 4
    • 80051543217 scopus 로고    scopus 로고
    • Global epidemiology of meningococcal disease
    • Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine 2009;275:851-63.
    • (2009) Vaccine , vol.275 , pp. 851-863
    • Harrison, L.H.1    Trotter, C.L.2    Ramsay, M.E.3
  • 5
    • 77953594002 scopus 로고    scopus 로고
    • The elusive meningococcal meningitis serogroup: A systematic review of serogroup B epidemiology
    • Racloz VN, Luiz SJ. The elusive meningococcal meningitis serogroup: A systematic review of serogroup B epidemiology. BMC Infect Dis 2010;10:175.
    • (2010) BMC Infect Dis , vol.10 , pp. 175
    • Racloz, V.N.1    Luiz, S.J.2
  • 6
    • 0031752295 scopus 로고    scopus 로고
    • Population genetics and molecular epidemiology of Neisseria meningitidis
    • Caugant DA. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998;106:505-25. (Pubitemid 28308237)
    • (1998) APMIS , vol.106 , Issue.5 , pp. 505-525
    • Caugant, D.A.1
  • 7
    • 84860998698 scopus 로고    scopus 로고
    • Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines
    • Ladhani SN, Flood JS, Ramsay ME, et al. Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines. Vaccine 2012;30:3710-6.
    • (2012) Vaccine , vol.30 , pp. 3710-3716
    • Ladhani, S.N.1    Flood, J.S.2    Ramsay, M.E.3
  • 8
    • 0020518256 scopus 로고
    • Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis
    • Finne J, Leinonen M, Makela PH. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 1983;322:155-7.
    • (1983) Lancet , vol.322 , pp. 155-157
    • Finne, J.1    Leinonen, M.2    Makela, P.H.3
  • 9
    • 50249119599 scopus 로고    scopus 로고
    • Genetics and evolution of Neisseria meningitidis: Importance for the epidemiology of meningococcal disease
    • Caugant DA. Genetics and evolution of Neisseria meningitidis: Importance for the epidemiology of meningococcal disease. Infect Gen Evolu 2008;8:558-65.
    • (2008) Infect Gen Evolu , vol.8 , pp. 558-565
    • Caugant, D.A.1
  • 10
    • 67349185861 scopus 로고    scopus 로고
    • Meningococcal carriage and disease - Population biology and evolution
    • Caugant DA, Maiden MCJ. Meningococcal carriage and disease - population biology and evolution. Vaccine 2009;27S:B64-B70.
    • (2009) Vaccine , vol.27 S
    • Caugant, D.A.1    Maiden, M.C.J.2
  • 11
    • 33747182586 scopus 로고    scopus 로고
    • Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19)
    • Law DSK, Lorange M, Ringuette L, et al. Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19). J Clin Microbiol 2006;44:2473-9.
    • (2006) J Clin Microbiol , vol.44 , pp. 2473-2479
    • Law, D.S.K.1    Lorange, M.2    Ringuette, L.3
  • 12
    • 84859972093 scopus 로고    scopus 로고
    • Invasive serogroup B Neisseria meningitidis in Québec, Canada, 2003-2010: Persistence of the ST-269 clone since it first emerged in 2003
    • Zhou J, Lefebvre B, Deng S, et al. Invasive serogroup B Neisseria meningitidis in Québec, Canada, 2003-2010: Persistence of the ST-269 clone since it first emerged in 2003. J Clin Microbiol 50:1545-51.
    • J Clin Microbiol , vol.50 , pp. 1545-1551
    • Zhou, J.1    Lefebvre, B.2    Deng, S.3
  • 13
    • 79957680694 scopus 로고    scopus 로고
    • Detection of a geographical and endemic cluster of hyper-invasive meningococcal strains
    • Bertrand S, Van Meerveme E, De Baere T, et al. Detection of a geographical and endemic cluster of hyper-invasive meningococcal strains. Microbes Infect 2011;13:684-90.
    • (2011) Microbes Infect , vol.13 , pp. 684-690
    • Bertrand, S.1    Van Meerveme, E.2    De Baere, T.3
  • 14
    • 85013713800 scopus 로고    scopus 로고
    • Community outbreak of group B meningococcal diseasae in southwest France - December 2008 to September 2009
    • Delisle E, Larrieu S, Simoes J, et al. Community outbreak of group B meningococcal diseasae in southwest France - December 2008 to September 2009. Euro Surveill 2010;15:19655.
    • (2010) Euro Surveill , vol.15 , pp. 19655
    • Delisle, E.1    Larrieu, S.2    Simoes, J.3
  • 15
    • 84880353023 scopus 로고    scopus 로고
    • Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the U.S.
    • Mandal S, Wu HM, MacNeil JR, et al. Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the U.S. Clin Infect Dis 2013;57:344-8.
    • (2013) Clin Infect Dis , vol.57 , pp. 344-348
    • Mandal, S.1    Wu, H.M.2    MacNeil, J.R.3
  • 16
    • 84870522017 scopus 로고    scopus 로고
    • The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: Potential implications of emergence of new strains
    • Gilca R, Deceuninck G, Lefebvre B, et al. The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: Potential implications of emergence of new strains. PLoS One 2012;7:e50659.
    • (2012) PLoS One , vol.7
    • Gilca, R.1    Deceuninck, G.2    Lefebvre, B.3
  • 17
    • 84872869549 scopus 로고    scopus 로고
    • First meningitis B vaccine could be available in UK next year
    • Iacobucci G. First meningitis B vaccine could be available in UK next year. Br Med J 2012;345:e7867.
    • (2012) Br Med J , vol.345
    • Iacobucci, G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.